CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 1, 2016, Pages 225-237

  Rogers, Michael A ^a   Kalter, Verena ^a   Marcias, Gemma ^a   Zapatka, Marc ^a   Barbus, Sebastian ^a   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Actin; Adherens junctions; c MET; CITED4; Claudins; Colorectal cancer; Ezrin; Gene expression; Microarray; Tight junctions

Indexed keywords

BETA CATENIN; CLAUDIN 4; CLAUDIN 7; COLLAGEN TYPE 4; CREB BINDING PROTEIN P300 INTERACTING TRANSACTIVATOR WITH ED RICH TAIL MEMBER 4 PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; EZRIN; F ACTIN; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VINCULIN; VITRONECTIN; ACTIN; CITED4 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR MARKER;

ACTIN FILAMENT; ADULT; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL CYCLE G2 PHASE; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; COLONY FORMATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FOCAL ADHESION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING; ADHERENS JUNCTION; ANTAGONISTS AND INHIBITORS; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ACTINS; ADHERENS JUNCTIONS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TIGHT JUNCTIONS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84953637817     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2011-5     Document Type: Article

References (54)

1. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bauerle T, Wallwiener M, Holland-Letz T, Hofner T, Sprick M, Scharpff M, Marme F, Sinn HP, Pantel K, Weichert W, Trumpp A (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31:539–544
2. Bai L, Merchant JL (2007) Role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett 581:5904–5910
3. Bamforth SD, Braganca J, Eloranta JJ, Murdoch JN, Marques FIR, Kranc KR, Farza H, Henderson DJ, Hurst HC, Bhattacharya S (2001) Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 29:469–474
4. Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13:64–75
5. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915–925
6. Bjarnadottir TK, Fredriksson R, Hoglund PJ, Gloriam DE, Lagerstrom MC, Schioth HB (2004) The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics 84:23–33
7. Bjarnadottir TK, Fredriksson R, Schioth HB (2007) The Adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci 64:2104–2119
8. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK (2011) The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 11:65
9. Braganca J, Swingler T, Marques FIR, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S (2002) Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 277:8559–8565
10. Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599
11. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622
12. Coopman PJ, Mueller SC (2006) The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 241:159–173
13. Darido C, Buchert M, Pannequin J, Bastide P, Zalzali H, Mantamadiotis T, Bourgaux JF, Garambois V, Jay P, Blache P, Joubert D, Hollande F (2008) Defective claudin-7 regulation by Tcf-4 and Sox-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res 68:4258–4268
14. Fox SB, Braganca J, Turley H, Campo L, Han C, Gatter KC, Bhattacharya S, Harris AL (2004) CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1 alpha. Cancer Res 64:6075–6081
15. Freedman SJ, Sun ZYJ, Kung AL, France DS, Wagner G, Eck MJ (2003) Structural basis for negative regulation of hypoxia-inducible factor-1 alpha by CITED2. Nat Struct Biol 10:504–512
16. Gao H, Guan M, Sun Z, Bai C (2015) High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis. Tumour Biol 36:515–520
17. Gong X, Carmon KS, Lin QS, Thomas A, Yi J, Liu QY (2012) LGR6 Is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS One 7:e37137
18. Hartsock A, Nelson WJ (2008) Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta Biomembr 1778:660–669
19. Havenith MG, Arends JW, Simon R, Volovics A, Wiggers T, Bosman FT (1988) Type-IV collagen immunoreactivity in colorectal-cancer—prognostic value of basement-membrane deposition. Cancer 62:2207–2211
20. Huang DW, Sherman BT, Lempicki RA (2009a) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57
21. Huang DW, Sherman BT, Lempicki RA (2009b) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1–13
22. Huang KT, Takano EA, Mikeska T, Byrne DJ, Dobrovic A, Fox SB (2011) Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer. Breast Cancer Res Treat 130:319–329
23. Jiang W, Hiscox S, Matsumoto K, Nakamura T (1999) Hepatocyte growth factor scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29:209–248
24. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai J, Kerr D, Aaltonen LA, Arango D, Kruhoffer M, Orntoft TF, Andersen CL, Gruidl M, Kamath VP, Eschrich S, Yeatman TJ, Sieber OM (2009) Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin Cancer Res 15:7642–7651
25. Kallio MA, Tuimala JT, Hupponen T, Klemela P, Gentile M, Scheinin I, Koski M, Kaki J, Korpelainen EI (2011) Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genom 12:507
26. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, Hildebrand D, Moldenhauer G, Langbein L, Franke WW, Weitz J, Zoller M (2007) A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 5:553–567
27. Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36:4562–4569
28. Liu Y, Yu XF, Zou J, Luo ZH (2015) Prognostic value of c-Met in colorectal cancer: a meta-analysis. World J Gastroenterol 21:3706–3710
29. Lum AM, Wang BB, Beck-Engeser GB, Li L, Channa N, Wabl M (2010) Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer 10:40
30. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46:165–186
31. Mees ST, Mennigen R, Spieker T, Rijcken E, Senninger N, Haier J, Bruewer M (2009) Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis 24:361–368
32. Meniel V, Song F, Phesse T, Young M, Poetz O, Parry L, Jenkins JR, Williams GT, Dunwoodie SL, Watson A, Clarke AR (2013) Cited1 deficiency suppresses intestinal tumorigenesis. PLoS Genetics 9:1003638
33. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283–1298
34. Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H (2008) Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 75:177–185
35. Nasu T, Oku Y, Takifuji K, Hotta T, Yokoyama S, Matsuda K, Tamura K, Ieda J, Yamamoto N, Takemura S, Nakamura Y, Yamaue H (2013) Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression. J Surg Res 185:136–142
36. Orian-Rousseau V, Chen LF, Sleeman JP, Herrlich P, Ponta H (2002) CD44 is required for two consecutive steps in HGF/c-met signaling. Genes Develop 16:3074–3086
37. Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T (2008) Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep 19:953–959
38. Patara M, Santos EMM, Coudry RD, Soares FA, Ferreira FO, Rossi BM (2011) Ezrin expression as a prognostic marker in colorectal adenocarcinoma. Pathol Oncol Res 17:827–833
39. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347–361
40. Saotome I, Curto M, McClatchey AI (2004) Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6:855–864
41. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, van Engeland M, Ting AH, Jair K, Yu W, Toyota M, Imai K, Ahuja N, Herman JG, Baylin SB (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3:1709–1723
42. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu CS, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274
43. Tatum R, Zhang Y, Salleng K, Lu Z, Lin JJ, Lu Q, Jeansonne BG, Ding L, Chen YH (2010) Renal salt wasting and chronic dehydration in claudin-7-deficient mice. Am J Physiol Renal Physiol 298:F24–F34
44. Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P (2006) Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer 119:792–800
45. Tews B, Roerig P, Hartmann C, Hahn M, Felsberg J, Blaschke B, Sabel M, Kunitz A, Toedt G, Neben K, Benner A, von Deimling A, Reifenberger G, Lichter P (2007) Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene 26:5010–5016
46. Tomasini-Johansson BR, Sundberg C, Lindmark G, Gailit JO, Rubin K (1994) Vitronectin in colorectal adenocarcinoma—synthesis by stromal cells in culture. Exp Cell Res 214:303–312
47. Torres-Martin M, Franco-Hernandez C, Martinez-Glez V, de Campos JM, Isla A, Casartelli C, Rey JA (2008) Mutational analysis of the CITED4 gene in glioblastomas. Cancer Genet Cytogenet 185:114–116
48. Turksen K, Troy TC (2011) Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 1816:73–79
49. Ueda J, Semba S, Chiba H, Sawada N, Seo Y, Kasuga M, Yokozaki H (2007) Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 74:32–41
50. van der Horst E, Chinn L, Wang M, Velilla T, Tran H, Madrona Y, Lam A, Ji M, Hoey TC, Sato AK (2009) Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia 11:355–364
51. Yahata T, Takedatsu H, Dunwoodie SL, Braganca J, Swingler T, Withington SL, Hur J, Coser KR, Isselbacher KJ, Bhattacharya S, Shioda T (2002) Cloning of mouse cited4, a member of the CITED family p300/CBP-binding transcriptional coactivators: induced expression in mammary epithelial cells. Genomics 80:601–613
52. Yang ZL, Huo LJ, Chen H, Ni BB, Xiang J, Kang L, Wang L, Peng JS, Yuan YF, Wang JP (2013) Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Med Oncol 30:586
53. Yoshida T, Sekine T, Aisaki K, Mikami T, Kanno J, Okayasu I (2011) CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid. J Gastroenterol 46:339–349
54. Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749–755